Context Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-21.32	-23.96	-14.84	-10.46	6.64	-6.38
Depreciation & Amortization	0.04	0.06	0.09	0	0	0
Share-Based Compensation	1.03	1.08	0.98	0.51	0.22	0.78
Other Operating Activities	0.57	1.78	0.22	1.15	-7.9	2.77
Operating Cash Flow	-19.68	-21.05	-13.55	-8.8	-1.03	-2.84
Capital Expenditures	0	0	-0.04	0	0	0
Other Investing Activities	-	-	-0.5	-0.25	-	-
Investing Cash Flow	0	0	-0.54	-0.25	0	0
Share Issuance / Repurchase	0	0	0	53.41	0	0
Debt Issued / Paid	0	0	0	0	0.15	1.96
Other Financing Activities	-	-	-0.1	4.98	1	-
Financing Cash Flow	0	0	-0.1	58.39	1.15	1.96
Net Cash Flow	-19.68	-21.05	-14.19	49.34	0.11	-0.88
Free Cash Flow	-19.68	-21.05	-13.59	-8.8	-1.03	-2.84
Free Cash Flow Per Share	-1.23	-1.32	-0.85	-3.10	-2.97	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).